Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's ...

An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

Tempus AI (TEM) stock is tanking following a short seller report that raised concerns about the company, its products, and ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

Spruce Point's short report sent Tempus AI stock down 20%. TEM shares were overvalued and risky to own even without the short ...

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.

Yahoo Finance host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

Spruce Point Capital Management has announced a new short position against Tempus AI Inc (NASDAQ:TEM). The short seller on ...

Spruce Point said Tempus’ revenue quality should be carefully scrutinized, because of signs of "aggressive accounting." ...

Shares of Tempus AI (NASDAQ: TEM) tumbled 4% after the company was targeted in a short-seller report by Spruce Point. The report raised serious concerns about the integrity of Tempus AI’s product, the ...